Literature DB >> 27340734

Risk Factors for Surgical Site Infections Following Anterior Cruciate Ligament Reconstruction.

Michael V Murphy1, Dongyi Tony Du2, Wei Hua2, Karoll J Cortez3, Melissa G Butler4, Robert L Davis4, Thomas A DeCoster5, Laura Johnson6, Lingling Li1, Cynthia Nakasato7, James D Nordin8, Mayur Ramesh6, Michael Schum9, Ann Von Worley9, Craig Zinderman2, Richard Platt1, Michael Klompas1.   

Abstract

OBJECTIVE To determine the effect of graft choice (allograft, bone-patellar tendon-bone autograft, or hamstring autograft) on deep tissue infections following anterior cruciate ligament (ACL) reconstructions. DESIGN Retrospective cohort study. SETTING AND POPULATION Patients from 6 US health plans who underwent ACL reconstruction from January 1, 2000, through December 31, 2008. METHODS We identified ACL reconstructions and potential postoperative infections using claims data. A hierarchical stratified sampling strategy was used to identify patients for medical record review to confirm ACL reconstructions and to determine allograft vs autograft tissue implanted, clinical characteristics, and infection status. We estimated infection rates overall and by graft type. We used logistic regression to assess the association between infections and patients' demographic characteristics, comorbidities, and choice of graft. RESULTS On review of 1,452 medical records, we found 55 deep wound infections. With correction for sampling weights, infection rates varied by graft type: 0.5% (95% CI, 0.3%-0.8%) with allografts, 0.6% (0.1%-1.5%) with bone-patellar tendon-bone autografts, and 2.5% (1.9%-3.1%) with hamstring autograft. After adjusting for potential confounders, we found an increased infection risk with hamstring autografts compared with allografts (odds ratio, 5.9; 95% CI, 2.8-12.8). However, there was no difference in infection risk among bone-patellar tendon-bone autografts vs allografts (odds ratio, 1.2; 95% CI, 0.3-4.8). CONCLUSIONS The overall risk for deep wound infections following ACL reconstruction is low but it does vary by graft type. Infection risk was highest in hamstring autograft recipients compared with allograft recipients and bone-patellar tendon-bone autograft recipients. Infect Control Hosp Epidemiol 2016;37:827-833.

Entities:  

Mesh:

Year:  2016        PMID: 27340734     DOI: 10.1017/ice.2016.65

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  5 in total

1.  Atopic dermatitis is a novel demographic risk factor for surgical site infection after anterior cruciate ligament reconstruction.

Authors:  Manabu Kawata; Yusuke Sasabuchi; Shuji Taketomi; Hiroshi Inui; Hiroki Matsui; Kiyohide Fushimi; Hideo Yasunaga; Sakae Tanaka
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-05-03       Impact factor: 4.342

2.  Hamstring autografts are associated with a high rate of contamination in anterior cruciate ligament reconstruction.

Authors:  Abdulaziz Z Alomar; Saud M Alfayez; Ali M Somily
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-08-29       Impact factor: 4.342

3.  Type of bone graft and primary diagnosis were associated with nosocomial surgical site infection after high tibial osteotomy: analysis of a national database.

Authors:  Manabu Kawata; Taisuke Jo; Shuji Taketomi; Hiroshi Inui; Ryota Yamagami; Hiroki Matsui; Kiyohide Fushimi; Hideo Yasunaga; Sakae Tanaka
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2020-04-01       Impact factor: 4.342

4.  Septic Arthritis Complicating Arthroscopic Anterior Cruciate Ligament Reconstruction: An Experience from a Tertiary-Care Hospital.

Authors:  Rania Abd El-Hamid El-Kady; Ahmed Mahmoud Fouad ElGuindy
Journal:  Infect Drug Resist       Date:  2022-07-13       Impact factor: 4.177

5.  Knee septic arthritis caused by α-hemolytic Streptococcus in a patient with a recent history of knee arthroscopy: a case report.

Authors:  Giovanni Balato; Tiziana Ascione; Paolino Iorio; Cristiano De Franco; Vincenzo De Matteo; Alessio D'Addona; Nicola Tammaro; Achille Pellegrino
Journal:  BMC Infect Dis       Date:  2019-10-24       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.